US Patent Issued to INVENTERA PHARMACEUTICALS on June 10 for "MRI contrast agent including T1 contrast material coated on surface of nanoparticle support" (South Korean Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,844, issued on June 10, was assigned to INVENTERA PHARMACEUTICALS INC. (Seoul, South Korea).

"MRI contrast agent including T1 contrast material coated on surface of nanoparticle support" was invented by Jin Woo Cheon (Seoul, South Korea) and Tae Hyun Shin (Yongin-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A magnetic resonance imaging (MRI) T1 contrast agent composition including T1 contrast material coated on the surface of a nanoparticle support and an imaging method using the MRI T1 contrast agent. The MRI T1 contrast agent composition has excellent T1 spin magnetic relaxation effects by modifying the paramagnetic T1 contrast m...